Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO)

Aydin D., Sendur M. A., KEFELİ U., Unal O. U., TAŞTEKİN D., Akyol M., ...More

JOURNAL OF BUON, vol.21, no.5, pp.1242-1249, 2016 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 21 Issue: 5
  • Publication Date: 2016
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1242-1249
  • Keywords: advanced, chemotherapy, prognostic factors, small bowel adenocarcinoma, SMALL-INTESTINE, SINGLE-INSTITUTION, PHASE-II, CHEMOTHERAPY, CANCER
  • Istanbul University Affiliated: Yes


Purpose: Small bowel adenocarcinoma (SBA) is a rare tumor of the gastrointestinal system with poor prognosis. Since these are rarely encountered tumors, there are limited numbers of studies investigating systemic treatment in advanced SBA. The purpose of this study was to evaluate the prognostic factors and systemic treatments in patients with advance SBA.